Assurance Infusion Recalls Multi-Drug Syringes Due to Sterility Concerns
Assurance Infusion is recalling specific lots of multi-drug injection syringes because of a lack of sterility assurance.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric, particularly given the risk of infection associated with a lack of sterility assurance in an injectable product.
Plain-English summary
Assurance Infusion is recalling a specific lot of BAC 150 mcg/BUP 2 mg/Hydrom 15 mg/Morp 20 mg/SUF 650 mcg/mL Injection in 20 mL syringes. The recall is being conducted due to a lack of sterility assurance for the product.
The affected product is identified by Lot 12172019@2 with an expiration date of 12/26/2019. The recall covers distribution nationwide within the United States.
Consumers and healthcare providers should stop using the affected syringes and contact Assurance Infusion at (713)533-8800 for further instructions.
The recalled product
- Product
- BAC 150 mcg/BUP 2 mg/Hydrom 15 mg/Morp 20 mg/SUF 650 mcg/mL Inj. in 20 mL syringe Assurance Infusion (713)533-8800
- Manufacturer
- Assurance Infusion
- Category
- Drug — Injectable
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 12172019@2 Exp. 12/26/2019
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 118 recalled by Assurance Infusion under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 118 products in this recall →Related recalls
Same manufacturer · Assurance Infusion
See all →- SevereAssurance Infusion Recalls Buprenorphine and Hydromorphone Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereAssurance Infusion Recalls Hydromorphone Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereAssurance Infusion Recalls Fentanyl Syringes Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereAssurance Infusion Recalls Morphine Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereAssurance Infusion Recalls Buprenorphine and Morphine Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
Same hazard · infection
See all →- SevereSafeguard US Operating LLC Recalls Compression Bandages Due to Degradation
FDA (Devices) · 2026-10-14
- SevereStryker Bard EP XT Decapolar Steerable Diagnostic EP Catheter Recalled for Sterile Barrier Breach
FDA (Devices) · 2026-10-14
- HighFDA Recalls Defective Blue Nitrile Patient Examination Gloves
FDA (Devices) · 2026-10-07
- SevereAurolab Trust Recalls FOCUS PI Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2026-10-07
- HighFDA Recalls Performance Pro Nitrile Gloves Due to Defects
FDA (Devices) · 2026-10-07
Similar recalls
- SevereInfusion Options Recalls Avastin Infusions Due to Sterility Concerns
FDA (Drugs) · 2019-08-21
- HighInfusion Options Recalls Azacitidine Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-08-21
- SevereFDA Recalls Tri-MIX Syringes Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-10-14
- SevereBaptist Health Recalls Ascorbic Acid Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-06-08
- SevereInfliximab Infusion Bags Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-08-21
- SevereAtezolizumab Infusion Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-08-21